Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.69
+0.17004.83%
Post-market: 3.690.00000.00%19:59 EDT
Volume:22.93M
Turnover:84.16M
Market Cap:1.95B
PE:-3.16
High:3.74
Open:3.62
Low:3.55
Close:3.52
52wk High:7.18
52wk Low:2.77
Shares:527.40M
Float Shares:415.00M
Volume Ratio:1.15
T/O Rate:5.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1684
EPS(LYR):-1.4410
ROE:-57.16%
ROA:-27.66%
PB:1.90
PE(LYR):-2.56

Loading ...

Cathie Wood’s ARK Investment buys 260K shares of Recursion Pharmaceuticals today

TIPRANKS
·
Jun 25

Recursion Pharmaceuticals director Bumpus Namandje disposes of 3,963 common shares worth $12,599.34

Reuters
·
Jun 23

Recursion Shareholders Reelect Directors and Approve Governance Matters

TIPRANKS
·
Jun 19

Recursion Pharmaceuticals holds annual shareholder meeting

Reuters
·
Jun 19

Nvidia-Related Stocks Rally. Applied Digital Up 11%; WhiteFiber And Nebius Up 5%; Nano-X And Arm Up 4%; CoreWeave, Serve Robotics And Lumentum Up 3%

Tiger Newspress
·
Jun 09

Recursion Pharma director Christopher Gibson disposes of 40,000 common shares for $144,800

Reuters
·
Jun 06

Recursion CEO and President Najat Khan sells 23,588 shares worth $84,459

Reuters
·
Jun 06

Recursion Pharma director Bumpus Namandje disposes of 4,386 common shares for $15,526.44

Reuters
·
Jun 05

Recursion Pharma director Blake Borgeson disposes of 30,000 shares worth $110,400

Reuters
·
Jun 05

Recursion to Present at Goldman Sachs Global Healthcare Conference

Reuters
·
Jun 02

Recursion to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Jun 02

Recursion grants inducement RSUs covering 2,991,840 shares to 33 new hires

Reuters
·
May 30

Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

THOMSON REUTERS
·
May 30

Recursion Pharmaceuticals director Christopher Gibson disposes of 40,000 common shares for $ 123,200

Reuters
·
May 28

Assessing Recursion Pharmaceuticals (RXRX) Valuation As Shares Lose Momentum In Recent Months

Simply Wall St.
·
May 24

Nvidia-Linked Shares Rally. Applied Digital up 18%; NEBIUS up 17%; WhiteFiber up 13%; ARM Holdings, Lumentum up 9% Each; CoreWeave up Nearly 5%

Tiger Newspress
·
May 21

Recursion Pharmaceuticals Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
May 15

Stock Track | Recursion Pharmaceuticals Soars 5.08% Intraday After Morgan Stanley Raises Price Target

Stock Track
·
May 14

Morgan Stanley Raises Price Target on Recursion Pharmaceuticals to $5.50 From $5, Keeps Equalweight Rating

MT Newswires Live
·
May 14

Recursion director Christopher Gibson disposes of 60,000 shares for $134,800

Reuters
·
May 09